Hi, I am Qiaojuan Shi, My LiveDNA is 86.22595
 
   
  Home
 
 
 
Dr. Qiaojuan Shi
 
Highest Degree: Ph.D. in Pharmacology from Zhejiang University, China
 
Institute: Zhejiang Academy of Medical Sciences, China
 
Area of Interest: Pharmacology and Toxicology
  •   Preclinical Pharmacology
  •   Biopharmaceuticals
  •   Immunohistochemistry
  •   Flow Cytometry
 
URL: http://livedna.org/86.22595
 
My SELECTED Publications
1:   Shi, Q.J., H. Wang, Z.X. Liu, S.H. Fang and X.M. Song et al., 2015. HAMI 3379, A Cyslt2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats. Neuroscience, 291: 53-69.
CrossRef  |  PubMed  |  
2:   Shi, Q.J., L. Xiao, B. Zhao, X.Y. Zhang and X.R. Wang et al., 2012. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats. Brain Res., 1484: 57-67.
CrossRef  |  
3:   Shi, W.Z., C.Z. Zhao, B. Zhao, Q.J. Shi and L.H. Zhang et al., 2012. Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient mice. Neurosci. Bull., 28: 680-692.
CrossRef  |  PubMed  |  
4:   Zhang, X.Y., X.R. Wang, D.M. Xu, S.Y. Yu and Q.J. Shi et al., 2013. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J. Pharmacol. Exp. Ther., 346: 328-341.
CrossRef  |  PubMed  |  
5:   Zhao, B., M. Zhang, X. Han, X.Y. Zhang and Q. Xing et al., 2013. Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism. PLoS One, 8: e85403-e85403.
CrossRef  |  Direct Link  |